Wegovys mechanism Wegovy can lead to significant weight loss in people with excess weight and obesity when used with lifestyle changes
Liver Disease: MASLD and NAFLD Metabolic dysfunction-associated steatotic liver disease (MASLD formerly NAFLD) affects approximately 1 in 3 UK adults with obesity
PloS One (2012) 7:e37187
Retatrutide as monotherapy in adults with type 2 diabetes inadequately controlled with diet and exercise alone: results from the phase 3 TRANSCEND-T2D-1 trial
Symptoms include indigestion, a bloated stomach, upper abdominal pain, nausea and vomiting, regurgitation of undigested food, loss of appetite, acid reflux, heartburn, and blood sugar fluctuations
[5] This includes testing of glucose tolerance, using a two-hour oral glucose tolerance test (GTT) in all women with PMOS